Combined Radiofrequency Ablation and Adjuvant Liposomal Chemotherapy: Effect of Chemotherapeutic Agent, Nanoparticle Size, and Circulation Time
- 1 October 2005
- journal article
- research article
- Published by Elsevier BV in Journal of Vascular and Interventional Radiology
- Vol. 16 (10), 1365-1371
- https://doi.org/10.1097/01.rvi.0000175324.63304.25
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Quantitative computed tomography analysis of local chemotherapy in liver tissue after radiofrequency ablation1Academic Radiology, 2004
- Review of Radiofrequency Ablation for Renal Cell CarcinomaClinical Cancer Research, 2004
- Radiofrequency ablation of bony metastatic diseaseClinical Radiology, 2004
- Radiofrequency Ablation of Hepatic Tumors: Increased Tumor Destruction with Adjuvant Liposomal Doxorubicin TherapyAmerican Journal of Roentgenology, 2002
- Image-guided Radiofrequency Tumor Ablation: Challenges and Opportunities—Part IIJournal of Vascular and Interventional Radiology, 2001
- Percutaneous Tumor Ablation: Increased Necrosis with Combined Radio-Frequency Ablation and Intratumoral Doxorubicin Injection in a Rat Breast Tumor ModelRadiology, 2001
- Phase I and pharmacokinetic study of a stable, polyethylene-glycolated liposomal doxorubicin in patients with solid tumorsCancer, 2001
- Percutaneous Tumor Ablation: Increased Coagulation by Combining Radio-frequency Ablation and Ethanol Instillation in a Rat Breast Tumor ModelRadiology, 2000
- Thermosensitive liposomes: Extravasation and release of contents in tumor microvascular networksInternational Journal of Radiation Oncology*Biology*Physics, 1996
- Limitations of tetrazolium salts in delineating infarcted brainActa Neuropathologica, 1984